Skip to main content

Table 3 Comparison of post-catherization diagnosis and biomarkers between patients who had no event and patients who had combined events by the 1-year follow-up

From: Indoleamine 2,3 dioxygenase (IDO) level as a marker for significant coronary artery disease

Parameters

No event (n = 274)

Combined events (n = 17)

p-value

All patients (N = 291)

   

Baseline hs-TnT

12.88 (3.09, 294.20)

16.92 (8.28, 124.90)

0.038

Baseline Kynurenine

5.23 (0.00, 11,731.00)

1.97 (0.00, 32.84)

0.036

Baseline IDO activity

0.15 (0.00, 4.58)

0.05 (0.00, 2.91)

0.159

Insignificant CAD/SVD patients (n = 152)

No event (n = 146)

Combined events (n = 6)

 

Baseline hs-TnT

11.59 (3.09, 141.50)

15.13 (12.89, 124.90)

0.111

Baseline Kynurenine

4.94 (0.00, 7892.33)

0.38 (0.00, 4.45)

0.017

Baseline IDO activity

0.14 (0.00, 4.13)

0.01 (0.00, 0.14)

0.023

DVD/TVD patients (n = 139)

No event (n = 128)

Combined events (n = 11)

 

Baseline hs-TnT

15.05 (4.53, 294.20)

17.13 (8.28, 61.03)

0.290

Baseline Kynurenine

5.70 (0.00, 11,731.00)

4.37 (0.38, 32.84)

0.264

Baseline IDO activity

0.16 (0.00, 4.58)

0.12 (0.01, 2.91)

0.767

  1. Data presented as frequency and percentage or median (minimum, maximum)
  2. A p-value < 0.05 indicates statistical significance
  3. Combined events: All cause death or myocardial infarction or recurrent chest pain
  4. CAD, coronary artery disease; SVD, single-vessel disease; LM, left main; hs-TnT, high-sensitivity troponin T; IDO, indoleamine 2,3 dioxygenase; DVD, double-vessel disease; TVD, triple-vessel disease